Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is a recognized leading innovative player in the brain monitoring space. The company continues to be at the forefront of what is next in neurology technology. … Continue reading →

As the world learns more about the novel SARS-CoV-2 virus, the evidence about neurological symptoms developed by patients who suffered from COVID-19 is mounting, and the market for Brain Scientific’s (OTCQB: BRSF) innovative products appears to expand. A recent article published … Continue reading →

BRSF is about to enter into a merger agreement to acquire Piezo Motion, a leading piezo motor technology developer Piezo Motion’s technology will be deployed to leverage massive amounts of data that can be analyzed by artificial intelligence to assist … Continue reading →

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has partnered with Ehave Inc., a provider of digital therapeutics for the psychedelic and mental health sectors. The partnership is intended to change the fact that … Continue reading →

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has developed cutting-edge tech that bridges the widening gap in access to quality care. The company’s clinical-grade neurological devices, NeuroCap(TM) and NeuroEEG(TM), are portable, cost-efficient, easy-to-use, … Continue reading →

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, is bringing to market new technology that allows EEG testing to be deployed rapidly and accurately in children and adolescents. The Pediatric NeuroCap is intended to … Continue reading →

As a leading innovator in brain diagnostics technology, BRSF appears well placed to spot and predict driving forces behind the industry’s expected rapid growth  BRSF’s Marketing Director was featured in an article giving prediction about key trends driving brain monitoring … Continue reading →

The company has developed and brought to market a pediatric NeuroCap  EEG testing in pediatrics may help diagnose autism, one of the fastest-growing developmental disorders in the US, and provide better treatment for pediatric patients with epilepsy  COVID-19 made the … Continue reading →

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company, has created powerful yet affordable solutions that bring brain diagnostics to settings where it was previously impossible or difficult to conduct neurological testing. Concussions resulting from head trauma in … Continue reading →

BRSF has partnered with Ehave to conduct research connected to biochemical biomarkers concerning psychedelic drug administration Psychedelic drugs show promise in treating neurological disorders, including chronic pain, depression, and PTSD, but more research is needed BRSF’s E-Tattoo is poised to … Continue reading →